Trader-101楼主curtaincall:
some time's but if you know stocks the way that I do it's the best way to get a good buy on a great stock you always buy when there's blood in the water and then you just wait it out
Trader-101楼主curtaincall:
Believe it or not AAN is probably in the top 20% of the best ranked stocks and that's why I pay attention to secondary offering or lock out expirations so that I can snatch up a few stocks that I would never be able to buy at such a good entry you have to think about long term I only day trade with 20,%of my holdings
Trader-101楼主curtaincall:
And the way that I picked that up I heard one of the best investors of our time said at a conference name of Warren Buffett from Berkshire Hathaway
Aaron's, Inc.股票讨论
Aaron's Company, Inc.(纽约证券交易所代码:AAN)是以租代购零售领域的知名实体,它宣布已签订最终协议,将被领先的金融科技组织IQventures Holdings, LLC以每股10.10美元的现金收购。该协议对亚伦公司的估值约为5.04亿美元。那个...
亚伦的公司签订了最终协议,将被IQVentures以每股10.10美元的价格收购
亚伦公司宣布了一项最终协议,将由IQVentures Holdings以每股10.10美元的现金收购,使该公司的估值约为5.04亿美元。该价格比亚伦在2024年6月14日的收盘价高出34.0%,比90天成交量加权平均股价高出35.6%。
该交易已获批准...
对收益/指导的回应:
• $康姆泰克通讯(CMTL.US)$ +2.1%, $美光科技(MU.US)$+1.5%
其他新闻:
• $Amylyx Pharmaceuticals(AMLX.US)$ +9.3%(获得 FDA 对 Relyvrio 的批准)
• $Ready Capital(RC.US)$ +4.9%(股票回购授权增加了2500万美元)
• $Blue Apron(APRN.US)$ +2.5%(首席财务官将辞职)
• $福陆(FLR.US)$ +2.3%(美国能源部延长了福陆牵头的萨凡纳河合同)
• $Immuneering(IMRX.US)$ +1.6%(回复...
对收益/指导的回应:
$Liberty Energy(LBRT.US)$ +11.6%, $F5 Inc(FFIV.US)$ +6.9%, $Encore缆线(WIRE.US)$ + 5.6%, $Archer Daniels Midland(ADM.US)$ +5.5%, $毕达菲尔特银行(NTB.US)$ +5%, $奥尔巴尼国际(AIN.US)$ +5%, $3M(MMM.US)$ +4.0%,
其他新闻:
$Shell Midstream(SHLX.US)$ +10%(美国壳牌将以15.85美元/单位总价值19.6亿美元的价格收购公众持有的SHLX的所有单位)
$BridgeBio Pharma(BBIO.US)$...
$雷克兰医疗工业(LAKE.US)$ 3/20 strike 20 call option
$Alpha Pro Tech(APT.US)$ 3/20 strike 12.5 call option
$Moderna(MRNA.US)$3/20 strike 30 call option
$Enphase Energy(ENPH.US)$3/20 strike 40 put option continuation
有时候我喜欢仔细检查当天最大的输家,然后在我度过了糟糕的一天的原石中挑选钻石。
$Aaron's, Inc.(AAN.US)$ 未加工的钻石
$Baudax Bio Inc(BXRX.US)$
$Esperion Therapeutics(ESPR.US)$
$Proteostasis Therapeutics Inc(PTI.US)$
暂无评论